- Home
- PPIH vs AVTX Comparison
PPIH vs AVTX Comparison
Compare PPIH & AVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PPIH
- AVTX
- Stock Information
- Founded
- PPIH 1993
- AVTX 2011
- Country
- PPIH United States
- AVTX United States
- Employees
- PPIH N/A
- AVTX N/A
- Industry
- PPIH Pollution Control Equipment
- AVTX Biotechnology: Pharmaceutical Preparations
- Sector
- PPIH Industrials
- AVTX Health Care
- Exchange
- PPIH Nasdaq
- AVTX Nasdaq
- Market Cap
- PPIH 253.5M
- AVTX 248.3M
- IPO Year
- PPIH N/A
- AVTX 2015
- Fundamental
- Price
- PPIH $27.27
- AVTX $18.04
- Analyst Decision
- PPIH
- AVTX Strong Buy
- Analyst Count
- PPIH 0
- AVTX 9
- Target Price
- PPIH N/A
- AVTX $30.14
- AVG Volume (30 Days)
- PPIH 117.3K
- AVTX 382.6K
- Earning Date
- PPIH 09-15-2025
- AVTX 11-07-2025
- Dividend Yield
- PPIH N/A
- AVTX N/A
- EPS Growth
- PPIH N/A
- AVTX N/A
- EPS
- PPIH 1.25
- AVTX N/A
- Revenue
- PPIH $181,198,000.00
- AVTX $441,000.00
- Revenue This Year
- PPIH $25.58
- AVTX N/A
- Revenue Next Year
- PPIH $8.72
- AVTX N/A
- P/E Ratio
- PPIH $21.80
- AVTX N/A
- Revenue Growth
- PPIH 14.90
- AVTX N/A
- 52 Week Low
- PPIH $8.81
- AVTX $3.39
- 52 Week High
- PPIH $33.09
- AVTX $19.41
- Technical
- Relative Strength Index (RSI)
- PPIH 54.59
- AVTX 68.13
- Support Level
- PPIH $24.40
- AVTX $16.77
- Resistance Level
- PPIH $29.94
- AVTX $19.01
- Average True Range (ATR)
- PPIH 1.76
- AVTX 1.52
- MACD
- PPIH 0.24
- AVTX 0.15
- Stochastic Oscillator
- PPIH 54.79
- AVTX 77.95
About PPIH Perma-Pipe International Holdings Inc.
Perma-Pipe International Holdings Inc is engaged in the manufacture and sale of products in the reportable segment of Piping Systems. The company engineers, designs, manufactures, and sells specialty piping systems and leak detection systems. Specialty piping systems include insulated and jacketed district heating and cooling piping systems for efficient energy distribution from central energy plants to multiple locations, primary and secondary containment piping systems for transporting chemicals, hazardous fluids, and petroleum products, and the coating and insulation of oil and gas gathering and transmission pipelines. It operates in the United States, Canada, the Middle East, Europe, India, and other countries.
About AVTX Avalo Therapeutics Inc.
Avalo Therapeutics Inc is a clinical-stage biotechnology company focused on the treatment of immune dysregulation. The company's asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).